These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29524481)

  • 1. Changes in metformin use and other antihyperglycemic therapies after insulin initiation in patients with type 2 diabetes.
    Pilla SJ; Dotimas JR; Maruthur NM; Clark JM; Yeh HC
    Diabetes Res Clin Pract; 2018 May; 139():221-229. PubMed ID: 29524481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Insulin Initiation in Patients with Type 2 Diabetes: An Analysis of the Look AHEAD Randomized Trial.
    Pilla SJ; Yeh HC; Juraschek SP; Clark JM; Maruthur NM
    J Gen Intern Med; 2018 Jun; 33(6):839-846. PubMed ID: 29352421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of non-insulin diabetes medicines after insulin initiation: A retrospective cohort study.
    Xu Y; Pilla SJ; Alexander GC; Murimi IB
    PLoS One; 2019; 14(2):e0211820. PubMed ID: 30759121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial antihyperglycemic drug therapy among 241 327 adults with newly identified diabetes from 2005 through 2010: a surveillance, prevention, and management of diabetes mellitus (SUPREME-DM) study.
    Raebel MA; Xu S; Goodrich GK; Schroeder EB; Schmittdiel JA; Segal JB; O'Connor PJ; Nichols GA; Lawrence JM; Kirchner HL; Elston Lafata J; Butler M; Newton KM; Steiner JF
    Ann Pharmacother; 2013 Oct; 47(10):1280-91. PubMed ID: 24259692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent antihyperglycemic prescribing trends for US privately insured patients with type 2 diabetes.
    Cohen FJ; Neslusan CA; Conklin JE; Song X
    Diabetes Care; 2003 Jun; 26(6):1847-51. PubMed ID: 12766121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lifetime health consequences and cost-effectiveness of rosiglitazone in combination with metformin for the treatment of type 2 diabetes in Spain.
    Shearer AT; Bagust A; Ampudia-Blasco FJ; Martínez-Lage Alvarez B; Pérez Escolano I; París G
    Pharmacoeconomics; 2006; 24 Suppl 1():49-59. PubMed ID: 16800162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Relationship Between Metformin and Serum Prostate-Specific Antigen Levels.
    Jayalath VH; Ireland C; Fleshner NE; Hamilton RJ; Jenkins DJ
    Prostate; 2016 Nov; 76(15):1445-53. PubMed ID: 27403913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihyperglycemic Medications: A Claims-Based Estimate of First-line Therapy Use Prior to Initialization of Second-line Medications.
    Tseng YJ; Steinberg G; Fox KP; Armstrong J; Mandl KD
    Diabetes Care; 2017 Nov; 40(11):1500-1505. PubMed ID: 28903978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to and factors associated with insulin initiation in patients with type 2 diabetes mellitus.
    Machado-Alba JE; Machado-Duque ME; Moreno-Gutierrez PA
    Diabetes Res Clin Pract; 2015 Mar; 107(3):332-7. PubMed ID: 25648389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
    Goo AK; Carson DS; Bjelajac A
    J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin: an antihyperglycemic agent for treatment of type II diabetes.
    Melchior WR; Jaber LA
    Ann Pharmacother; 1996 Feb; 30(2):158-64. PubMed ID: 8835050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation of insulin therapy in patients with type 2 diabetes: An observational study.
    Zerovnik S; Kos M; Locatelli I
    Acta Pharm; 2022 Mar; 72(1):147-157. PubMed ID: 36651525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in insulin initiation and treatment intensification among patients with type 2 diabetes.
    Patrick AR; Fischer MA; Choudhry NK; Shrank WH; Seeger JD; Liu J; Avorn J; Polinski JM
    J Gen Intern Med; 2014 Feb; 29(2):320-7. PubMed ID: 24101534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight changes following the initiation of new anti-hyperglycaemic therapies.
    Nichols GA; Gomez-Caminero A
    Diabetes Obes Metab; 2007 Jan; 9(1):96-102. PubMed ID: 17199724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.
    Berkowitz SA; Krumme AA; Avorn J; Brennan T; Matlin OS; Spettell CM; Pezalla EJ; Brill G; Shrank WH; Choudhry NK
    JAMA Intern Med; 2014 Dec; 174(12):1955-62. PubMed ID: 25347323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Trends in Antidiabetes Drug Usage in the U.S.: Real-world Evidence in Patients Newly Diagnosed With Type 2 Diabetes.
    Montvida O; Shaw J; Atherton JJ; Stringer F; Paul SK
    Diabetes Care; 2018 Jan; 41(1):69-78. PubMed ID: 29109299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin versus Insulin in the Management of Pre-Gestational Diabetes Mellitus in Pregnancy and Gestational Diabetes Mellitus at the Korle Bu Teaching Hospital: A Randomized Clinical Trial.
    Beyuo T; Obed SA; Adjepong-Yamoah KK; Bugyei KA; Oppong SA; Marfoh K
    PLoS One; 2015; 10(5):e0125712. PubMed ID: 25945500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin monotherapy for type 2 diabetes mellitus.
    Saenz A; Fernandez-Esteban I; Mataix A; Ausejo M; Roque M; Moher D
    Cochrane Database Syst Rev; 2005 Jul; (3):CD002966. PubMed ID: 16034881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications.
    Liao EP
    Am J Med; 2012 Oct; 125(10):S1-2. PubMed ID: 22998891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.